Skip to main content
logo
BioVersys AG (SWX:BIOV)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
26.60
-0.80 (-2.92%)
At close: Jul 31, 2026

BioVersys AG Ratios and Metrics

Millions CHF. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23
Market Cap
156143--
Market Cap Growth
-20.88%---
Enterprise Value
94.9682.8300
Last Close Price
26.6024.40--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23
PS Ratio
49.0557.82--
PB Ratio
2.602.39--
P/TBV Ratio
2.502.29--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
29.9133.56--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.360.361.291.83
Net Debt / Equity Ratio
-1.00-1.00-1.36-1.27
Net Debt / EBITDA Ratio
3.043.040.790.63
Net Debt / FCF Ratio
2.702.700.930.93
Asset Turnover
0.040.040.040.03
Quick Ratio
9.279.273.373.03
Current Ratio
10.1010.103.563.59
Return on Equity (ROE)
-61.94%-61.94%-194.40%-213.40%
Return on Assets (ROA)
-31.77%-31.77%-54.17%-51.80%
Return on Capital Employed (ROCE)
-37.31%-37.31%-74.76%-71.36%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23
Buyback Yield / Dilution
-68.49%-68.49%-11.60%-
Total Shareholder Return
-68.49%-68.49%-11.60%-